This CPB has been revised to state that subcutaneous peritoneal ascites pump (e.g., the alfa-pump System) is considered experimental, investigational, or unproven for the management of ascites; and other indications including prevention of multidrug-resistant bacterial infections, repair of hernia, and treatment of hepato-cellular carcinoma.